H

ello, everyone, and how are you today? We are just fine, thank you, now that the Pharmalot campus settled down. The shortest person is off and running to her summer job and the official mascots are now quietly snoozing in their respective corners. As for us, we are quaffing more cups of stimulation, which reports indicate is a good idea, and invite you to join us, as always. Meanwhile, here are some items of interest. Hope you conquer the world today …

The Food and Drug Administration wants to institute rigorous new safety standards for how immediate-release opioids are prescribed, The Wall Street Journal reports. The agency plans to require drug makers to make available expanded training for doctors, nurses, and other health-care professionals who administer the immediate-release medicines. The approach would expand existing safety measures already required on extended-release pain drugs.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Early in my career the FDA pounded the phrase “It is not our job to regulate the practice of medicine”. They have strayed mightily with this new opioid practice guideline, which while well intended, is for all practical purposes unenforceable.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy